Supplement: CRISPR in the Courthouse
An Interview with Law Professor Jacob Sherkow
Growing Antibody Industry in China Sees Major Opportunities
Yet, Challenges Remain as Companies Need More Talent and Resources to Market Globally
BioTrinity Conference Focuses on NextGen Healthcare
Meeting Highlights Array of Technologies and Promising Methodologies
Supplement: Pushing the Boundaries of CRISPR
Innovations in Genome Editing on Multiple Fronts
For full access to this article login to GEN Select now.
Teasing Out Circulating Tumor DNA
New Advances Suggest That the Warning Attached to Many Biofluid-Based Diagnostic Tests May Be Temporary
- Cancer metastasis causes 90% of all cancer-related deaths. Scientists agree that the metastases occur when cancer cells are shed from the primary tumor, carried by the peripheral blood, and deposited at a distal site to create a new colony. An ability to etect circulating tumor cells (CTCs) or cell-free ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.